查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1596218

呼吸吸入器市場：按產品類型、年齡層、模式、適應症和最終用戶分類 - 全球預測 2025-2030

Respiratory Inhalers Market by Product Type (Dry Powder Inhaler, Metered Dose Inhaler, Nebulizer), Age Group (Adults, Pediatric), Mode, Disease Indication, End-Use - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 196 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年呼吸吸入器市場價值為29.6億美元，預計到2024年將達到32.4億美元，複合年成長率為9.74%，到2030年將達到56.8億美元。

呼吸吸入器市場包括各種用於將藥物直接輸送到肺部的設備，主要用於患有氣喘和慢性阻塞性肺病等慢性呼吸道疾病的人。這些吸入器的需求源於空氣污染、吸煙和老年人口不斷增加導致的呼吸道疾病的日益普及。其應用對於提供快速緩解和長期藥物控制非常重要，從而提高患者的依從性和生活品質。最終用途多種多樣，包括家庭護理場所、醫院和診所，凸顯了對攜帶式且易於使用的設備的需求。影響市場成長的關鍵因素包括吸入器技術的進步，例如提供劑量追蹤和患者提醒以提高用藥依從性的智慧吸入器。生物療法和數位健康技術的出現正在推動市場走向個人化醫療解決方案，並代表著巨大的潛在機會。然而，挑戰依然存在，高成本、濫用的可能性以及影響市場擴張的監管障礙等限制因素。關於一次性吸入器的環境問題也引發了永續性問題。創新和研究的重點領域包括開發更環保的設備、利用機器學習演算法改進吸入技術以及整合更先進的物聯網功能進行資料分析。市場越來越傾向於數位解決方案和永續實踐，這表明對技術先進和環保產品的需求不斷成長。與醫療保健提供者和高科技公司的合作可以提供有價值的夥伴關係來開發創新解決方案。因此，該行業必須適應監管環境，投資於研發，並克服設備濫用和負擔能力等挑戰。透過利用這些對消費者需求和監管環境的競爭考察，公司可以利用新機會並確保競爭優勢和市場成長機會。

主要市場統計
基準年[2023] 29.6億美元
預測年份 [2024] 32.4億美元
預測年份 [2030] 56.8億美元
複合年成長率（%） 9.74%

市場動態：快速發展的呼吸吸入器市場的關鍵市場洞察

供需的動態交互作用正在改變呼吸吸入器市場。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，並了解消費行為及其對製造成本的影響，並更清楚地了解對採購趨勢的影響。

  • 市場促進因素
    • 全球空氣污染率上升和呼吸道疾病爆發
    • 提高消費者對肺部疾病的認知
    • 政府對改善氣喘治療的興趣日益濃厚
  • 市場限制因素
    • 政府對吸入器核准有嚴格的規定
  • 市場機會
    • 創新智慧吸入器簡介
    • 開發有效的吸入劑配方
  • 市場挑戰
    • 吸入器的不正確使用和操作問題

波特的五力：駕馭呼吸吸入器市場的策略工具

波特的五力框架是理解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢、解決弱點並避免潛在的挑戰，以確保更強大的市場地位。

PESTLE分析：了解呼吸吸入器市場的外部影響

外部宏觀環境因素在塑造呼吸吸入器市場的績效動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並為他們做出積極主動的決策做好準備。

市場佔有率分析 了解呼吸吸入器市場的競爭格局

對呼吸吸入器市場的詳細市場佔有率分析可以對供應商的表現進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV 定位矩陣呼吸吸入器市場供應商的績效評估

FPNV定位矩陣是評估呼吸吸入器市場供應商的重要工具。此矩陣允許業務組織根據供應商的商務策略和產品滿意度評估供應商，從而做出符合其目標的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析和建議，以規劃呼吸吸入器市場的成功之路

對於旨在加強其在全球市場的影響力的公司來說，呼吸吸入器市場的策略分析至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：對當前市場環境的詳細審查、主要企業的廣泛資料、對其在市場中的影響力和整體影響力的評估。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，以幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 全球空氣污染率上升和呼吸道疾病爆發
      • 意識提升
      • 政府專注於改善氣喘治療
    • 抑制因素
      • 政府對吸入器核准的嚴格規定
    • 機會
      • 創新智慧吸入器簡介
      • 開發有效的吸入劑配方
    • 任務
      • 吸入器的不正確使用和操作問題
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章呼吸吸入器市場：依產品類型

  • 乾粉吸入器
  • 定量吸入器
  • 噴霧器
  • 緩霧吸入器

第7章呼吸吸入器市場：依年齡層

  • 成人
  • 小兒科

第8章呼吸吸入器市場模式

  • 數位化操作裝置
  • 手動操作裝置

第9章呼吸吸入器市場：依疾病適應症

  • 氣喘
  • 慢性阻塞性肺病
  • 肺動脈高血壓

第10章呼吸吸入器市場：依最終用途

  • 診所和醫院
  • 藥局
  • 呼吸護理中心

第11章美洲呼吸吸入器市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第12章亞太呼吸吸入器市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第13章歐洲、中東和非洲呼吸吸入器市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第14章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
  • 戰略分析和建議

公司名單

  • AstraZeneca PLC
  • Beximco Pharmaceuticals Ltd.
  • CH Boehringer Sohn Ko. KG
  • Cadila Healthcare Ltd.
  • Chiesi Farmaceutici SpA
  • Cipla Limited
  • GlaxoSmithKline PLC
  • Heltman Medikal AS
  • Koninklijke Philips NV
  • Lupin Limited
  • Merck & Co., Inc.
  • Microlife Corporation
  • Novartis AG
  • Opko Health, Inc.
  • Rossmax International Ltd.
  • Teva Pharmaceutical Industries Ltd.
Product Code: MRR-DD5AD9F59777

The Respiratory Inhalers Market was valued at USD 2.96 billion in 2023, expected to reach USD 3.24 billion in 2024, and is projected to grow at a CAGR of 9.74%, to USD 5.68 billion by 2030.

The respiratory inhalers market encompasses a range of devices used for the delivery of medication directly into the lungs, primarily benefiting individuals with chronic respiratory conditions like asthma and COPD. The necessity for these inhalers arises from the increasing prevalence of respiratory disorders driven by air pollution, smoking, and a rising geriatric population. Their application is critical in delivering rapid relief or long-term control medication, thereby improving patient compliance and quality of life. The end-use scope spans across home care settings, hospitals, and clinics, emphasizing the need for portable and easy-to-use devices. Key factors influencing the market growth include advancements in inhaler technology, such as smart inhalers that provide dosage tracking and patient reminders, which enhance medication adherence. The emergence of biologic therapies and digital health technologies represents significant potential opportunities, pushing the market toward personalized medicine solutions. However, challenges persist, with limitations like high costs, potential for incorrect usage, and regulatory hurdles impacting market expansion. Environmental concerns regarding disposable inhalers also pose sustainability issues. For innovation and research, focus areas include developing more eco-friendly devices, improving inhalation techniques through machine learning algorithms, and integrating more advanced IoT features for data analytics. The market shows a growing inclination towards digital solutions and sustainable practices, indicating an upward trend in demand for technologically advanced and environmentally friendly products. Collaborations with healthcare providers and tech companies could provide valuable partnerships to develop innovative solutions. Thus, the industry must navigate regulatory landscapes and invest in R&D to overcome challenges like device misuse and affordability. By leveraging these insights into consumer demands and regulatory setups, companies can capitalize on emerging opportunities, ensuring competitive advantage and market growth.

KEY MARKET STATISTICS
Base Year [2023] USD 2.96 billion
Estimated Year [2024] USD 3.24 billion
Forecast Year [2030] USD 5.68 billion
CAGR (%) 9.74%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Respiratory Inhalers Market

The Respiratory Inhalers Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rise in air pollution rate worldwide and occurrence of respiratory disorders
    • Increasing consumer awareness of pulmonary disorders
    • Growing government focus on improving asthma care
  • Market Restraints
    • Stringent regulations for inhaler approvals by the government
  • Market Opportunities
    • Introduction of innovative smart inhalers
    • Development of effective inhaler medication formulations
  • Market Challenges
    • Incorrect usage and operational issues in inhalers

Porter's Five Forces: A Strategic Tool for Navigating the Respiratory Inhalers Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Respiratory Inhalers Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Respiratory Inhalers Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Respiratory Inhalers Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Respiratory Inhalers Market

A detailed market share analysis in the Respiratory Inhalers Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Respiratory Inhalers Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Respiratory Inhalers Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Respiratory Inhalers Market

A strategic analysis of the Respiratory Inhalers Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Respiratory Inhalers Market, highlighting leading vendors and their innovative profiles. These include AstraZeneca PLC, Beximco Pharmaceuticals Ltd., C.H. Boehringer Sohn Ko. KG, Cadila Healthcare Ltd., Chiesi Farmaceutici S.p.A., Cipla Limited, GlaxoSmithKline PLC, Heltman Medikal A.S., Koninklijke Philips N.V., Lupin Limited, Merck & Co., Inc., Microlife Corporation, Novartis AG, Opko Health, Inc., Rossmax International Ltd., and Teva Pharmaceutical Industries Ltd..

Market Segmentation & Coverage

This research report categorizes the Respiratory Inhalers Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product Type, market is studied across Dry Powder Inhaler, Metered Dose Inhaler, Nebulizer, and Soft Mist Inhalers.
  • Based on Age Group, market is studied across Adults and Pediatric.
  • Based on Mode, market is studied across Digitally Operated Devices and Manually Operated Devices.
  • Based on Disease Indication, market is studied across Asthma, Chronic Obstructive Pulmonary Disease, and Pulmonary Arterial Hypertension.
  • Based on End-Use, market is studied across Clinics & Hospitals, Pharmacies, and Respiratory Care Center.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rise in air pollution rate worldwide and occurrence of respiratory disorders
      • 5.1.1.2. Increasing consumer awareness of pulmonary disorders
      • 5.1.1.3. Growing government focus on improving asthma care
    • 5.1.2. Restraints
      • 5.1.2.1. Stringent regulations for inhaler approvals by the government
    • 5.1.3. Opportunities
      • 5.1.3.1. Introduction of innovative smart inhalers
      • 5.1.3.2. Development of effective inhaler medication formulations
    • 5.1.4. Challenges
      • 5.1.4.1. Incorrect usage and operational issues in inhalers
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Respiratory Inhalers Market, by Product Type

  • 6.1. Introduction
  • 6.2. Dry Powder Inhaler
  • 6.3. Metered Dose Inhaler
  • 6.4. Nebulizer
  • 6.5. Soft Mist Inhalers

7. Respiratory Inhalers Market, by Age Group

  • 7.1. Introduction
  • 7.2. Adults
  • 7.3. Pediatric

8. Respiratory Inhalers Market, by Mode

  • 8.1. Introduction
  • 8.2. Digitally Operated Devices
  • 8.3. Manually Operated Devices

9. Respiratory Inhalers Market, by Disease Indication

  • 9.1. Introduction
  • 9.2. Asthma
  • 9.3. Chronic Obstructive Pulmonary Disease
  • 9.4. Pulmonary Arterial Hypertension

10. Respiratory Inhalers Market, by End-Use

  • 10.1. Introduction
  • 10.2. Clinics & Hospitals
  • 10.3. Pharmacies
  • 10.4. Respiratory Care Center

11. Americas Respiratory Inhalers Market

  • 11.1. Introduction
  • 11.2. Argentina
  • 11.3. Brazil
  • 11.4. Canada
  • 11.5. Mexico
  • 11.6. United States

12. Asia-Pacific Respiratory Inhalers Market

  • 12.1. Introduction
  • 12.2. Australia
  • 12.3. China
  • 12.4. India
  • 12.5. Indonesia
  • 12.6. Japan
  • 12.7. Malaysia
  • 12.8. Philippines
  • 12.9. Singapore
  • 12.10. South Korea
  • 12.11. Taiwan
  • 12.12. Thailand
  • 12.13. Vietnam

13. Europe, Middle East & Africa Respiratory Inhalers Market

  • 13.1. Introduction
  • 13.2. Denmark
  • 13.3. Egypt
  • 13.4. Finland
  • 13.5. France
  • 13.6. Germany
  • 13.7. Israel
  • 13.8. Italy
  • 13.9. Netherlands
  • 13.10. Nigeria
  • 13.11. Norway
  • 13.12. Poland
  • 13.13. Qatar
  • 13.14. Russia
  • 13.15. Saudi Arabia
  • 13.16. South Africa
  • 13.17. Spain
  • 13.18. Sweden
  • 13.19. Switzerland
  • 13.20. Turkey
  • 13.21. United Arab Emirates
  • 13.22. United Kingdom

14. Competitive Landscape

  • 14.1. Market Share Analysis, 2023
  • 14.2. FPNV Positioning Matrix, 2023
  • 14.3. Competitive Scenario Analysis
  • 14.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. AstraZeneca PLC
  • 2. Beximco Pharmaceuticals Ltd.
  • 3. C.H. Boehringer Sohn Ko. KG
  • 4. Cadila Healthcare Ltd.
  • 5. Chiesi Farmaceutici S.p.A.
  • 6. Cipla Limited
  • 7. GlaxoSmithKline PLC
  • 8. Heltman Medikal A.S.
  • 9. Koninklijke Philips N.V.
  • 10. Lupin Limited
  • 11. Merck & Co., Inc.
  • 12. Microlife Corporation
  • 13. Novartis AG
  • 14. Opko Health, Inc.
  • 15. Rossmax International Ltd.
  • 16. Teva Pharmaceutical Industries Ltd.

LIST OF FIGURES

  • FIGURE 1. RESPIRATORY INHALERS MARKET RESEARCH PROCESS
  • FIGURE 2. RESPIRATORY INHALERS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL RESPIRATORY INHALERS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL RESPIRATORY INHALERS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL RESPIRATORY INHALERS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL RESPIRATORY INHALERS MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL RESPIRATORY INHALERS MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL RESPIRATORY INHALERS MARKET SIZE, BY AGE GROUP, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL RESPIRATORY INHALERS MARKET SIZE, BY AGE GROUP, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL RESPIRATORY INHALERS MARKET SIZE, BY MODE, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL RESPIRATORY INHALERS MARKET SIZE, BY MODE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL RESPIRATORY INHALERS MARKET SIZE, BY DISEASE INDICATION, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL RESPIRATORY INHALERS MARKET SIZE, BY DISEASE INDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. GLOBAL RESPIRATORY INHALERS MARKET SIZE, BY END-USE, 2023 VS 2030 (%)
  • FIGURE 15. GLOBAL RESPIRATORY INHALERS MARKET SIZE, BY END-USE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. AMERICAS RESPIRATORY INHALERS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. AMERICAS RESPIRATORY INHALERS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. UNITED STATES RESPIRATORY INHALERS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 19. UNITED STATES RESPIRATORY INHALERS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. ASIA-PACIFIC RESPIRATORY INHALERS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. ASIA-PACIFIC RESPIRATORY INHALERS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. EUROPE, MIDDLE EAST & AFRICA RESPIRATORY INHALERS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 23. EUROPE, MIDDLE EAST & AFRICA RESPIRATORY INHALERS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 24. RESPIRATORY INHALERS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 25. RESPIRATORY INHALERS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. RESPIRATORY INHALERS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL RESPIRATORY INHALERS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL RESPIRATORY INHALERS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL RESPIRATORY INHALERS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. RESPIRATORY INHALERS MARKET DYNAMICS
  • TABLE 7. GLOBAL RESPIRATORY INHALERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL RESPIRATORY INHALERS MARKET SIZE, BY DRY POWDER INHALER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL RESPIRATORY INHALERS MARKET SIZE, BY METERED DOSE INHALER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL RESPIRATORY INHALERS MARKET SIZE, BY NEBULIZER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL RESPIRATORY INHALERS MARKET SIZE, BY SOFT MIST INHALERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL RESPIRATORY INHALERS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL RESPIRATORY INHALERS MARKET SIZE, BY ADULTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL RESPIRATORY INHALERS MARKET SIZE, BY PEDIATRIC, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL RESPIRATORY INHALERS MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL RESPIRATORY INHALERS MARKET SIZE, BY DIGITALLY OPERATED DEVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL RESPIRATORY INHALERS MARKET SIZE, BY MANUALLY OPERATED DEVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL RESPIRATORY INHALERS MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL RESPIRATORY INHALERS MARKET SIZE, BY ASTHMA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL RESPIRATORY INHALERS MARKET SIZE, BY CHRONIC OBSTRUCTIVE PULMONARY DISEASE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL RESPIRATORY INHALERS MARKET SIZE, BY PULMONARY ARTERIAL HYPERTENSION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL RESPIRATORY INHALERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL RESPIRATORY INHALERS MARKET SIZE, BY CLINICS & HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL RESPIRATORY INHALERS MARKET SIZE, BY PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL RESPIRATORY INHALERS MARKET SIZE, BY RESPIRATORY CARE CENTER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. AMERICAS RESPIRATORY INHALERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 27. AMERICAS RESPIRATORY INHALERS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 28. AMERICAS RESPIRATORY INHALERS MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
  • TABLE 29. AMERICAS RESPIRATORY INHALERS MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 30. AMERICAS RESPIRATORY INHALERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 31. AMERICAS RESPIRATORY INHALERS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 32. ARGENTINA RESPIRATORY INHALERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 33. ARGENTINA RESPIRATORY INHALERS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 34. ARGENTINA RESPIRATORY INHALERS MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
  • TABLE 35. ARGENTINA RESPIRATORY INHALERS MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 36. ARGENTINA RESPIRATORY INHALERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 37. BRAZIL RESPIRATORY INHALERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 38. BRAZIL RESPIRATORY INHALERS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 39. BRAZIL RESPIRATORY INHALERS MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
  • TABLE 40. BRAZIL RESPIRATORY INHALERS MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 41. BRAZIL RESPIRATORY INHALERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 42. CANADA RESPIRATORY INHALERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 43. CANADA RESPIRATORY INHALERS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 44. CANADA RESPIRATORY INHALERS MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
  • TABLE 45. CANADA RESPIRATORY INHALERS MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 46. CANADA RESPIRATORY INHALERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 47. MEXICO RESPIRATORY INHALERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 48. MEXICO RESPIRATORY INHALERS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 49. MEXICO RESPIRATORY INHALERS MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
  • TABLE 50. MEXICO RESPIRATORY INHALERS MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 51. MEXICO RESPIRATORY INHALERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 52. UNITED STATES RESPIRATORY INHALERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 53. UNITED STATES RESPIRATORY INHALERS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 54. UNITED STATES RESPIRATORY INHALERS MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
  • TABLE 55. UNITED STATES RESPIRATORY INHALERS MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 56. UNITED STATES RESPIRATORY INHALERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 57. UNITED STATES RESPIRATORY INHALERS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 58. ASIA-PACIFIC RESPIRATORY INHALERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 59. ASIA-PACIFIC RESPIRATORY INHALERS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 60. ASIA-PACIFIC RESPIRATORY INHALERS MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
  • TABLE 61. ASIA-PACIFIC RESPIRATORY INHALERS MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 62. ASIA-PACIFIC RESPIRATORY INHALERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 63. ASIA-PACIFIC RESPIRATORY INHALERS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 64. AUSTRALIA RESPIRATORY INHALERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 65. AUSTRALIA RESPIRATORY INHALERS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 66. AUSTRALIA RESPIRATORY INHALERS MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
  • TABLE 67. AUSTRALIA RESPIRATORY INHALERS MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 68. AUSTRALIA RESPIRATORY INHALERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 69. CHINA RESPIRATORY INHALERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 70. CHINA RESPIRATORY INHALERS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 71. CHINA RESPIRATORY INHALERS MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
  • TABLE 72. CHINA RESPIRATORY INHALERS MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 73. CHINA RESPIRATORY INHALERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 74. INDIA RESPIRATORY INHALERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 75. INDIA RESPIRATORY INHALERS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 76. INDIA RESPIRATORY INHALERS MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
  • TABLE 77. INDIA RESPIRATORY INHALERS MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 78. INDIA RESPIRATORY INHALERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 79. INDONESIA RESPIRATORY INHALERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 80. INDONESIA RESPIRATORY INHALERS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 81. INDONESIA RESPIRATORY INHALERS MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
  • TABLE 82. INDONESIA RESPIRATORY INHALERS MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 83. INDONESIA RESPIRATORY INHALERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 84. JAPAN RESPIRATORY INHALERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 85. JAPAN RESPIRATORY INHALERS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 86. JAPAN RESPIRATORY INHALERS MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
  • TABLE 87. JAPAN RESPIRATORY INHALERS MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 88. JAPAN RESPIRATORY INHALERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 89. MALAYSIA RESPIRATORY INHALERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 90. MALAYSIA RESPIRATORY INHALERS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 91. MALAYSIA RESPIRATORY INHALERS MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
  • TABLE 92. MALAYSIA RESPIRATORY INHALERS MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 93. MALAYSIA RESPIRATORY INHALERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 94. PHILIPPINES RESPIRATORY INHALERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 95. PHILIPPINES RESPIRATORY INHALERS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 96. PHILIPPINES RESPIRATORY INHALERS MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
  • TABLE 97. PHILIPPINES RESPIRATORY INHALERS MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 98. PHILIPPINES RESPIRATORY INHALERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 99. SINGAPORE RESPIRATORY INHALERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 100. SINGAPORE RESPIRATORY INHALERS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 101. SINGAPORE RESPIRATORY INHALERS MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
  • TABLE 102. SINGAPORE RESPIRATORY INHALERS MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 103. SINGAPORE RESPIRATORY INHALERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 104. SOUTH KOREA RESPIRATORY INHALERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 105. SOUTH KOREA RESPIRATORY INHALERS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 106. SOUTH KOREA RESPIRATORY INHALERS MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
  • TABLE 107. SOUTH KOREA RESPIRATORY INHALERS MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 108. SOUTH KOREA RESPIRATORY INHALERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 109. TAIWAN RESPIRATORY INHALERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 110. TAIWAN RESPIRATORY INHALERS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 111. TAIWAN RESPIRATORY INHALERS MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
  • TABLE 112. TAIWAN RESPIRATORY INHALERS MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 113. TAIWAN RESPIRATORY INHALERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 114. THAILAND RESPIRATORY INHALERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 115. THAILAND RESPIRATORY INHALERS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 116. THAILAND RESPIRATORY INHALERS MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
  • TABLE 117. THAILAND RESPIRATORY INHALERS MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 118. THAILAND RESPIRATORY INHALERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 119. VIETNAM RESPIRATORY INHALERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 120. VIETNAM RESPIRATORY INHALERS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 121. VIETNAM RESPIRATORY INHALERS MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
  • TABLE 122. VIETNAM RESPIRATORY INHALERS MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 123. VIETNAM RESPIRATORY INHALERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 124. EUROPE, MIDDLE EAST & AFRICA RESPIRATORY INHALERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 125. EUROPE, MIDDLE EAST & AFRICA RESPIRATORY INHALERS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 126. EUROPE, MIDDLE EAST & AFRICA RESPIRATORY INHALERS MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
  • TABLE 127. EUROPE, MIDDLE EAST & AFRICA RESPIRATORY INHALERS MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 128. EUROPE, MIDDLE EAST & AFRICA RESPIRATORY INHALERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 129. EUROPE, MIDDLE EAST & AFRICA RESPIRATORY INHALERS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 130. DENMARK RESPIRATORY INHALERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 131. DENMARK RESPIRATORY INHALERS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 132. DENMARK RESPIRATORY INHALERS MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
  • TABLE 133. DENMARK RESPIRATORY INHALERS MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 134. DENMARK RESPIRATORY INHALERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 135. EGYPT RESPIRATORY INHALERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 136. EGYPT RESPIRATORY INHALERS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 137. EGYPT RESPIRATORY INHALERS MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
  • TABLE 138. EGYPT RESPIRATORY INHALERS MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 139. EGYPT RESPIRATORY INHALERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 140. FINLAND RESPIRATORY INHALERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 141. FINLAND RESPIRATORY INHALERS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 142. FINLAND RESPIRATORY INHALERS MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
  • TABLE 143. FINLAND RESPIRATORY INHALERS MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 144. FINLAND RESPIRATORY INHALERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 145. FRANCE RESPIRATORY INHALERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 146. FRANCE RESPIRATORY INHALERS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 147. FRANCE RESPIRATORY INHALERS MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
  • TABLE 148. FRANCE RESPIRATORY INHALERS MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 149. FRANCE RESPIRATORY INHALERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 150. GERMANY RESPIRATORY INHALERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 151. GERMANY RESPIRATORY INHALERS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 152. GERMANY RESPIRATORY INHALERS MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
  • TABLE 153. GERMANY RESPIRATORY INHALERS MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 154. GERMANY RESPIRATORY INHALERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 155. ISRAEL RESPIRATORY INHALERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 156. ISRAEL RESPIRATORY INHALERS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 157. ISRAEL RESPIRATORY INHALERS MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
  • TABLE 158. ISRAEL RESPIRATORY INHALERS MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 159. ISRAEL RESPIRATORY INHALERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 160. ITALY RESPIRATORY INHALERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 161. ITALY RESPIRATORY INHALERS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 162. ITALY RESPIRATORY INHALERS MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
  • TABLE 163. ITALY RESPIRATORY INHALERS MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 164. ITALY RESPIRATORY INHALERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 165. NETHERLANDS RESPIRATORY INHALERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 166. NETHERLANDS RESPIRATORY INHALERS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 167. NETHERLANDS RESPIRATORY INHALERS MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
  • TABLE 168. NETHERLANDS RESPIRATORY INHALERS MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 169. NETHERLANDS RESPIRATORY INHALERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 170. NIGERIA RESPIRATORY INHALERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 171. NIGERIA RESPIRATORY INHALERS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 172. NIGERIA RESPIRATORY INHALERS MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
  • TABLE 173. NIGERIA RESPIRATORY INHALERS MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 174. NIGERIA RESPIRATORY INHALERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 175. NORWAY RESPIRATORY INHALERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 176. NORWAY RESPIRATORY INHALERS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 177. NORWAY RESPIRATORY INHALERS MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
  • TABLE 178. NORWAY RESPIRATORY INHALERS MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 179. NORWAY RESPIRATORY INHALERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 180. POLAND RESPIRATORY INHALERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 181. POLAND RESPIRATORY INHALERS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 182. POLAND RESPIRATORY INHALERS MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
  • TABLE 183. POLAND RESPIRATORY INHALERS MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 184. POLAND RESPIRATORY INHALERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 185. QATAR RESPIRATORY INHALERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 186. QATAR RESPIRATORY INHALERS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 187. QATAR RESPIRATORY INHALERS MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
  • TABLE 188. QATAR RESPIRATORY INHALERS MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 189. QATAR RESPIRATORY INHALERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 190. RUSSIA RESPIRATORY INHALERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 191. RUSSIA RESPIRATORY INHALERS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 192. RUSSIA RESPIRATORY INHALERS MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
  • TABLE 193. RUSSIA RESPIRATORY INHALERS MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 194. RUSSIA RESPIRATORY INHALERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 195. SAUDI ARABIA RESPIRATORY INHALERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 196. SAUDI ARABIA RESPIRATORY INHALERS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 197. SAUDI ARABIA RESPIRATORY INHALERS MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
  • TABLE 198. SAUDI ARABIA RESPIRATORY INHALERS MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 199. SAUDI ARABIA RESPIRATORY INHALERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 200. SOUTH AFRICA RESPIRATORY INHALERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 201. SOUTH AFRICA RESPIRATORY INHALERS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 202. SOUTH AFRICA RESPIRATORY INHALERS MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
  • TABLE 203. SOUTH AFRICA RESPIRATORY INHALERS MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 204. SOUTH AFRICA RESPIRATORY INHALERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 205. SPAIN RESPIRATORY INHALERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 206. SPAIN RESPIRATORY INHALERS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 207. SPAIN RESPIRATORY INHALERS MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
  • TABLE 208. SPAIN RESPIRATORY INHALERS MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 209. SPAIN RESPIRATORY INHALERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 210. SWEDEN RESPIRATORY INHALERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 211. SWEDEN RESPIRATORY INHALERS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 212. SWEDEN RESPIRATORY INHALERS MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
  • TABLE 213. SWEDEN RESPIRATORY INHALERS MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 214. SWEDEN RESPIRATORY INHALERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 215. SWITZERLAND RESPIRATORY INHALERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 216. SWITZERLAND RESPIRATORY INHALERS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 217. SWITZERLAND RESPIRATORY INHALERS MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
  • TABLE 218. SWITZERLAND RESPIRATORY INHALERS MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 219. SWITZERLAND RESPIRATORY INHALERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 220. TURKEY RESPIRATORY INHALERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 221. TURKEY RESPIRATORY INHALERS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 222. TURKEY RESPIRATORY INHALERS MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
  • TABLE 223. TURKEY RESPIRATORY INHALERS MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 224. TURKEY RESPIRATORY INHALERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 225. UNITED ARAB EMIRATES RESPIRATORY INHALERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 226. UNITED ARAB EMIRATES RESPIRATORY INHALERS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 227. UNITED ARAB EMIRATES RESPIRATORY INHALERS MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
  • TABLE 228. UNITED ARAB EMIRATES RESPIRATORY INHALERS MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 229. UNITED ARAB EMIRATES RESPIRATORY INHALERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 230. UNITED KINGDOM RESPIRATORY INHALERS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 231. UNITED KINGDOM RESPIRATORY INHALERS MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
  • TABLE 232. UNITED KINGDOM RESPIRATORY INHALERS MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
  • TABLE 233. UNITED KINGDOM RESPIRATORY INHALERS MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
  • TABLE 234. UNITED KINGDOM RESPIRATORY INHALERS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 235. RESPIRATORY INHALERS MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 236. RESPIRATORY INHALERS MARKET, FPNV POSITIONING MATRIX, 2023